logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Remus Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    78788
    INE0O5T01011
    139.278683
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    REMUS
    82.75
    1390.51
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.52
    10
    0
     
Zeal Aqua standalone net profit rises 280.95% in the March 2024 quarter
Jun 01,2024
Net profit of Zeal Aqua rose 280.95% to Rs 4.80 crore in the quarter ended March 2024 as against Rs 1.26 crore during the previous quarter ended March 2023. Sales declined 0.46% to Rs 65.04 crore in the quarter ended March 2024 as against Rs 65.34 crore during the previous quarter ended March 2023.

For the full year,net profit rose 17.30% to Rs 8.27 crore in the year ended March 2024 as against Rs 7.05 crore during the previous year ended March 2023. Sales rose 9.68% to Rs 397.80 crore in the year ended March 2024 as against Rs 362.69 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales65.0465.34 0 397.80362.69 10
OPM %11.616.27 -5.325.23 -
PBDT5.982.84 111 15.2413.51 13
PBT4.801.26 281 10.258.18 25
NP4.801.26 281 8.277.05 17